Literature DB >> 23948922

Increased susceptibility to amyloid-β toxicity in rat brain microvascular endothelial cells under hyperglycemic conditions.

Cristina Carvalho1, Paige S Katz, Somhrita Dutta, Prasad V G Katakam, Paula I Moreira, David W Busija.   

Abstract

We hypothesized that hyperglycemia-induced mitochondrial dysfunction and oxidative stress are closely associated with amyloid-β peptide (Aβ) toxicity in endothelial cells. Brain microvascular endothelial cells from rat (RBMEC) and mice (MBMEC) were isolated from adult Sprague-Dawley rats and homozygous db/db (Leprdb/Leprdb) and heterozygous (Dock7m/Leprdb) mice, and cultured under normo- and hyperglycemic conditions for 7 d followed by 24 h exposure to Aβ1-40. Some experiments were also performed with two mitochondrial superoxide (O2•-) scavengers, MitoTempo and Peg-SOD. Cell viability was measured by the Alamar blue assay and mitochondrial membrane potential (ΔΨm) by confocal microscopy. Mitochondrial O2•- and hydrogen peroxide (H2O2) production was assessed by fluorescence microscopy and H2O2 production was confirmed by microplate reader. Hyperglycemia or Aβ1-40 alone did not affect cell viability in RBMEC. However, the simultaneous presence of high glucose and Aβ1-40 reduced cell viability and ΔΨm, and enhanced mitochondrial O2•- and H2O2 production. MitoTempo and PEG-SOD prevented Aβ1-40 toxicity. Interestingly, MBMEC presented a similar pattern of alterations with db/db cultures presenting higher susceptibility to Aβ1-40. Overall, our results show that high glucose levels increase the susceptibility of brain microvascular endothelial cells to Aβ toxicity supporting the idea that hyperglycemia is a major risk factor for vascular injury associated with AD.

Entities:  

Keywords:  Alzheimer's disease; amyloid-β peptide; brain endothelial cells; mitochondria; type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 23948922      PMCID: PMC4570500          DOI: 10.3233/JAD-130464

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells.

Authors:  Jingqi Yan; Ziyan Zhang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2011-05-27       Impact factor: 9.261

3.  Amyloid-β neurotoxicity restricts glucose window for neuronal survival in rat hippocampal slice cultures.

Authors:  Xiaonan Wang; Xiuzhen Song; Toshihiro Takata; Yoshiaki Miichi; Koichi Yokono; Takashi Sakurai
Journal:  Exp Gerontol       Date:  2010-07-22       Impact factor: 4.032

4.  Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase.

Authors:  Steven C Rogers; Xiaomin Zhang; Gohar Azhar; Shaoke Luo; Jeanne Y Wei
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-04-12       Impact factor: 6.053

Review 5.  Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Authors:  Cristina Carvalho; Sónia C Correia; Renato X Santos; Susana Cardoso; Paula I Moreira; Timothy A Clark; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 6.  Diabetes, vascular complications and antiplatelet therapy: open problems.

Authors:  A M Cerbone; N Macarone-Palmieri; G Saldalamacchia; A Coppola; G Di Minno; A A Rivellese
Journal:  Acta Diabetol       Date:  2008-12-02       Impact factor: 4.280

Review 7.  Neurodegenerative disorders associated with diabetes mellitus.

Authors:  Michael Ristow
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

8.  Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure.

Authors:  Paula I Moreira; Maria S Santos; António M Moreno; Raquel Seiça; Catarina R Oliveira
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

9.  Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain.

Authors:  Rosario Scalia; Yulan Gong; Brett Berzins; Li Juan Zhao; Kumar Sharma
Journal:  Diabetes       Date:  2007-04-19       Impact factor: 9.461

10.  Depression in the elderly: does family system play a role? A cross-sectional study.

Authors:  Ather M Taqui; Ahmed Itrat; Waris Qidwai; Zeeshan Qadri
Journal:  BMC Psychiatry       Date:  2007-10-25       Impact factor: 3.630

View more
  16 in total

1.  Sample multiplexing with cysteine-selective approaches: cysDML and cPILOT.

Authors:  Liqing Gu; Adam R Evans; Renã A S Robinson
Journal:  J Am Soc Mass Spectrom       Date:  2015-01-15       Impact factor: 3.109

2.  Impaired Mitochondrial Respiration in Large Cerebral Arteries of Rats with Type 2 Diabetes.

Authors:  Ivan Merdzo; Ibolya Rutkai; Venkata N L R Sure; Catherine A McNulty; Prasad V G Katakam; David W Busija
Journal:  J Vasc Res       Date:  2017-01-18       Impact factor: 1.934

3.  Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.

Authors:  Rajni Parthasarathy; K Martin Chow; Zahra Derafshi; Michael P Fautsch; John R Hetling; David W Rodgers; Louis B Hersh; David R Pepperberg
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

4.  The mechanistic target of rapamycin (mTOR) pathway and S6 Kinase mediate diazoxide preconditioning in primary rat cortical neurons.

Authors:  Somhrita Dutta; Ibolya Rutkai; Prasad V G Katakam; David W Busija
Journal:  J Neurochem       Date:  2015-07-01       Impact factor: 5.372

5.  Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.

Authors:  Wei-Ting Xuan; Han Wang; Peng Zhou; Ting Ye; Hua-Wu Gao; Shu Ye; Jing-Hui Wang; Meng-Lian Chen; Hang Song; Yan Wang; Biao Cai
Journal:  3 Biotech       Date:  2020-07-29       Impact factor: 2.406

Review 6.  Obesity and sex interact in the regulation of Alzheimer's disease.

Authors:  V Alexandra Moser; Christian J Pike
Journal:  Neurosci Biobehav Rev       Date:  2015-12-18       Impact factor: 8.989

Review 7.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

Review 8.  Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.

Authors:  Alla B Salmina; Ekaterina V Kharitonova; Yana V Gorina; Elena A Teplyashina; Natalia A Malinovskaya; Elena D Khilazheva; Angelina I Mosyagina; Andrey V Morgun; Anton N Shuvaev; Vladimir V Salmin; Olga L Lopatina; Yulia K Komleva
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

9.  Amyloid-beta disrupts calcium and redox homeostasis in brain endothelial cells.

Authors:  Ana Catarina R G Fonseca; Paula I Moreira; Catarina R Oliveira; Sandra M Cardoso; Paolo Pinton; Cláudia F Pereira
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

Review 10.  Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.

Authors:  Fuzhou Wang; Xirong Guo; Xiaofeng Shen; Richard M Kream; Kirk J Mantione; George B Stefano
Journal:  Med Sci Monit Basic Res       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.